Amgen to Pay $71 Million to State AG Charges

Overview


David Rosenbloom was co-counsel for a major pharmaceutical company in resolving allegations that it unlawfully promoted biologic medications for uses not approved by the U.S. Food and Drug Administration. Read the full article.